TITLE

Isoflurane Preconditioning Confers Cardioprotection by Activation of ALDH2

AUTHOR(S)
Lang, Xiao-E; Wang, Xiong; Zhang, Ke-Rang; Lv, Ji-Yuan; Jin, Jian-Hua; Li, Qing-Shan
PUB. DATE
February 2013
SOURCE
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The volatile anesthetic, isoflurane, protects the heart from ischemia/reperfusion (I/R) injury. Aldehyde dehydrogenase 2 (ALDH2) is thought to be an endogenous mechanism against ischemia-reperfusion injury possibly through detoxification of toxic aldehydes. We investigated whether cardioprotection by isoflurane depends on activation of ALDH2.Anesthetized rats underwent 40 min of coronary artery occlusion followed by 120 min of reperfusion and were randomly assigned to the following groups: untreated controls, isoflurane preconditioning with and without an ALDH2 inhibitor, the direct activator of ALDH2 or a protein kinase C (PKCε) inhibitor. Pretreatment with isoflurane prior to ischemia reduced LDH and CK-MB levels and infarct size, while it increased phosphorylation of ALDH2, which could be blocked by the ALDH2 inhibitor, cyanamide. Isolated neonatal cardiomyocytes were treated with hypoxia followed by reoxygenation. Hypoxia/reoxygenation (H/R) increased cardiomyocyte apoptosis and injury which were attenuated by isoflurane and forced the activation of ALDH2. In contrast, the effect of isoflurane-induced protection was almost abolished by knockdown of ALDH2. Activation of ALDH2 and cardioprotection by isoflurane were substantially blocked by the PKCε inhibitor. Activation of ALDH2 by mitochondrial PKCε plays an important role in the cardioprotection of isoflurane in myocardium I/R injury.
ACCESSION #
87623389

 

Related Articles

  • Similarly Potent Inhibition of Adenylyl Cyclase by P-Site Inhibitors in Hearts from Wild Type and AC5 Knockout Mice. Braeunig, Joerg H.; Schweda, Frank; Han, Pyung-Lim; Seifert, Roland // PLoS ONE;Jul2013, Vol. 8 Issue 7, p1 

    Adenylyl cyclase type 5 (AC5) was described as major cardiac AC isoform. The knockout of AC5 (AC5KO) exerted cardioprotective effects in heart failure. Our study explored the impact of AC5KO on mouse heart AC activities and evaluated putative AC5-selective inhibitors. In cardiac membranes from...

  • Remote cardioprotection by direct peripheral nerve stimulation and topical capsaicin is mediated by circulating humoral factors. Redington, Kathrine; Disenhouse, Tara; Strantzas, Samuel; Gladstone, Rachel; Wei, Can; Tropak, Michael; Dai, Xiaojing; Manlhiot, Cedric; Li, Jing; Redington, Andrew // Basic Research in Cardiology;Mar2012, Vol. 107 Issue 2, p1 

    We have previously shown that remote ischemic preconditioning by limb ischemia (rIPC) or intra-arterial adenosine releases a dialyzable cardioprotective circulating factor(s), the release of which requires an intact neural connection to the limb and is blocked by pretreatment with S-nitroso-...

  • Natural Antioxidant-Isoliquiritigenin Ameliorates Contractile Dysfunction of Hypoxic Cardiomyocytes via AMPK Signaling Pathway. Xiaoyu Zhang; Ping Zhu; Xiuying Zhang; Yina Ma; Wenguang Li; Ji-Mei Chen; Hui-Ming Guo; Richard Bucala; Jian Zhuang; Ji Li // Mediators of Inflammation;2013, Vol. 2013, p1 

    Isoliquiritigenin (ISL), a simple chalcone-type flavonoid, is derived from licorice compounds and is mainly present in foods, beverages, and tobacco. Reactive oxygen species (ROS) is a critical factor involved in modulating cardiac stress response signaling during ischemia and reperfusion. We...

  • Stroma Cell-Derived Factor-1α Signaling Enhances Calcium Transients and Beating Frequency in Rat Neonatal Cardiomyocytes. Hadad, Ielham; Veithen, Alex; Springael, Jean–Yves; Sotiropoulou, Panagiota A.; Mendes Da Costa, Agnès; Miot, Françoise; Naeije, Robert; De Deken, Xavier; Entee, Kathleen Mc // PLoS ONE;Feb2013, Vol. 8 Issue 2, p1 

    Stroma cell-derived factor-1α (SDF-1α) is a cardioprotective chemokine, acting through its G-protein coupled receptor CXCR4. In experimental acute myocardial infarction, administration of SDF-1α induces an early improvement of systolic function which is difficult to explain solely by an...

  • Contractile Activity Regulates Inducible Nitric Oxide Synthase Expression and NOi Production in Cardiomyocytes via a FAK-Dependent Signaling Pathway. Chu, Miensheng; Koshman, Yevgeniya; Iyengar, Rekha; Kim, Taehoon; Russell, Brenda; Samarel, Allen M. // Journal of Signal Transduction;2012, p1 

    Intracellular nitric oxide (NOi) is a physiological regulator of excitation-contraction coupling, but is also involved in the development of cardiac dysfunction during hypertrophy and heart failure. To determine whether contractile activity regulates nitric oxide synthase (NOS) expression,...

  • Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia–reperfusion injury in rat heart. Riccarda Granata; Letizia Trovato; Maria Pia Gallo; Silvia Destefanis; Fabio Settanni; Francesca Scarlatti; Alessia Brero; Roberta Ramella; Marco Volante; Jorgen Isgaard; Renzo Levi; Mauro Papotti; Giuseppe Alloatti; Ezio Ghigo // Cardiovascular Research;Jul2009, Vol. 83 Issue 2, p303 

    : Aims The hypothalamic neuropeptide growth hormone-releasing hormone (GHRH) stimulates GH synthesis and release in the pituitary. GHRH also exerts proliferative effects in extrapituitary cells, whereas GHRH antagonists have been shown to suppress cancer cell proliferation. We investigated GHRH...

  • Phosphoinositide-3 Kinase Signaling in Cardiac Hypertrophy and Heart Failure. Aoyagi, Toshinori; Matsui, Takashi // Current Pharmaceutical Design;6/21/2011, Vol. 17 Issue 18, p1818 

    Heart failure, a major symptom in the progression of cardiac hypertrophy, is a critical risk factor for cardiac death. A large body of research has investigated cardioprotective mechanisms that prevent or minimize hypertrophy, identifying a variety of specific peptide hormones, growth factors,...

  • Signaling mechanisms mediating the positive inotropic response to apelin in the intact rat heart. Ezer, Péter; Perjés, Ábel; Skoumal, Réka; Simon, Mihály; Cziráki, Attila; Koller, Akos; Kónyi, Attila; Gábor Horváth, Iván; Ruskoaho, Heikki; Szokodi, István // Cardiologia Croatica;May/Jun2014, Vol. 9 Issue 5/6, p244 

    Background: Apelin is emerging as an important regulator of the cardiovascular system. We previously demonstrated that apelin is one of the most potent endogenous stimulators of myocardial contractility; however, the signal transduction pathways mediating this effect are still obscure. Here we...

  • P99 Nrg1beta enhances glucose uptake in cardiomyocytes via mTOR, Src and Akt. Pentassuglia, L; Morandi, C; Xu, L; Lebboukh, S; Brink, M // Cardiovascular Research;Jul2014, Vol. 103 Issue suppl_1, pS17 

    Background: Neuregulin (Nrg)1β is a growth factor that activates PI3K/Akt and Src/FAK via the ErbB2/ErbB4 receptors. Although it is currently in clinical trial to treat haert failure, it remains unclear which cellular mechanisms are responsible for its cardioprotective actions. Here we tested...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics